Piramal Pharma Limited (BOM:543635)
India flag India · Delayed Price · Currency is INR
189.70
-2.05 (-1.07%)
At close: Aug 8, 2025

Heartland Financial USA Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
252,385297,962170,52881,683--
Market Cap Growth
29.68%74.73%108.77%---
Enterprise Value
296,864341,742209,922130,128--
Last Close Price
189.70224.35128.7266.74--
PE Ratio
257.35326.96956.95---
PS Ratio
2.763.262.091.15--
PB Ratio
3.113.672.151.21--
P/TBV Ratio
9.5511.286.973.51--
P/FCF Ratio
-130.7358.30---
P/OCF Ratio
-33.3916.9816.88--
EV/Sales Ratio
3.253.732.571.84--
EV/EBITDA Ratio
21.4224.9218.4322.58--
EV/EBIT Ratio
50.2054.0145.62---
EV/FCF Ratio
-149.9471.77---
Debt / Equity Ratio
0.600.600.600.830.620.54
Debt / EBITDA Ratio
3.693.444.009.213.632.30
Debt / FCF Ratio
-21.3116.10---
Asset Turnover
-0.590.550.520.57-
Inventory Turnover
-1.581.691.941.87-
Quick Ratio
-0.750.610.640.690.82
Current Ratio
-1.541.251.261.341.47
Return on Equity (ROE)
-1.14%0.24%-2.77%6.11%-
Return on Assets (ROA)
-2.55%1.93%-0.20%2.96%-
Return on Capital (ROIC)
2.55%3.09%2.30%-0.24%3.60%-
Return on Capital Employed (ROCE)
-5.30%4.20%-5.70%10.50%
Earnings Yield
0.39%0.31%0.10%-2.28%--
FCF Yield
-0.77%1.71%-5.89%--
Dividend Yield
0.07%0.06%0.08%---
Payout Ratio
-15.88%--13.30%-
Buyback Yield / Dilution
-1.48%-3.67%-7.85%-0.95%-87.83%-
Total Shareholder Return
-1.41%-3.61%-7.76%-0.95%-87.83%-
Updated Jan 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.